Biological schizophrenia research
Munkvad, I.
Ugeskrift for Laeger 139(45): 2687-2688
1977
ISSN/ISBN: 0041-5782 PMID: 595154 Document Number: 117489
Document emailed within 1 workday
Related Documents
Shimazono, Y. 1976: Schizophrenia--biological consideration Seishin Shinkeigaku Zasshi 78(4): 251-256Otsuki, S. 1983: Schizophrenia--a biological approach Seishin Shinkeigaku Zasshi 85(10): 652-655
Gazdag, G.; Ungvari, G.S. 2011: Non-pharmacological biological therapies in schizophrenia Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 13(4): 233-238
Karas', G.A.; Lazarev, V.S. 1991: Use of various bibliometric methods in operative evaluation of research activities of the research institutions of medico- biological profile Vestnik Akademii Meditsinskikh Nauk SSSR 1991(4): 61-65
Mikolaĭskiĭ, M.V. 1985: Relation between biological and social factors in the differentiation of clinical forms of the course of schizophrenia Vrachebnoe Delo 11: 103-105
Morera, A.L.; Henry, M.; García-Hernández, A.; Fernández-López, L. 2007: Acute phase proteins as biological markers of negative psychopathology in paranoid schizophrenia Actas Espanolas de Psiquiatria 35(4): 249-252
Riles, S. 1997: New research on the treatment of schizophrenia Nursing Times 93(52): 47
Schulsinger, F. 1973: Schizophrenia research--tendencies Ugeskrift for Laeger 135(47): 2576-2577
Kringlen, E. 1978: The status of schizophrenia research Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(2): 65-69
Nordentoft, M. 2001: Etiological epidemiological schizophrenia research Ugeskrift for Laeger 163(35): 4715
Van den Bosch, R.J. 1985: Converging trends in schizophrenia research Nederlands Tijdschrift Voor Geneeskunde 129(25): 1179-1182
Liégeois, J.; Eyrolles, L.; Bruhwyler, J.; Delarge, J. 1998: Dopamine D4 receptors: a new opportunity for research on schizophrenia Current Medicinal Chemistry 5(2): 77-100
Schooler, N.R.; Keith, S.J. 1993: The clinical research base for the treatment of schizophrenia Psychopharmacology Bulletin 29(4): 431-446
Kubodera, N. 2011: Frontiers in vitamin D; basic research and clinical application. Exploratory research, biological characteristic and pharmacokinetics of eldecalcitol, a new active vitamin D derivative Clinical Calcium 21(11): 53-60
Chanpattana, W. 1999: The use of the stabilization period in ECT research in schizophrenia: I. a pilot study Journal of the Medical Association of Thailand 82(12): 1193-1199
Rybakowski, J. 1997: Progress in research on etiopathogenesis of schizophrenia in recent decades Psychiatria Polska 31(5): 513-526
Chanpattana, W.; Chakrabhand, M.L.; Kirdcharoen, N.; Tuntirungsee, Y.; Techakasem, P.; Prasertsuk, Y. 1999: The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation Journal of the Medical Association of Thailand 82(6): 558-568
Tamminga, C.A. 2001: Introduction: evaluating clinical trial data from schizophrenia research Journal of Clinical Psychiatry 62 Suppl. 9: 3-4
Abramova, L.I.; Kritskaia, V.P.; Meleshko, T.K.; Savina, T.D. 1987: Comparative clinico-psychological research on asthenic and sthenic remissions in attack-like schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(7): 1050-1056
Charles, G.; Ansseau, M. 1990: Diagnostic criteria for research in psychiatry (RDC) and guide for the diagnosis of affective disorders and schizophrenia (SADS) Acta Psychiatrica Belgica 90(5-6): 225-238